Get started
SHANGHAI FOSUN PHARMACEUTICAL GROUPSHANGHAI FOSUN PHARMACEUTICAL GROUPSHANGHAI FOSUN PHARMACEUTICAL GROUP

SHANGHAI FOSUN PHARMACEUTICAL GROUP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

600196 chart


Full chart

600196 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪58.15 B‬ CNY
Dividend yield (indicated)
1.34%
Price to earnings Ratio (TTM)
23.04
Basic EPS (TTM)
1.04 CNY
Net income (FY)
‪2.77 B‬ CNY
Revenue (FY)
‪40.75 B‬ CNY
Shares float
‪1.22 B‬
Beta (1Y)
0.98

Employees


Employees (FY)
‪40.56 K‬
Change (1Y)
+187 +0.46%
Revenue / Employee (1Y)
‪1.00 M‬ CNY
Net income / Employee (1Y)
‪68.30 K‬ CNY

About SHANGHAI FOSUN PHARMACEUTICAL GROUP


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
De Yong Wen
Website
fosunpharma.com
Headquarters
Shanghai
Founded
1994
ISIN
CNE000000X38
FIGI
BBG000C4SRF1
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

600196 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 600196.

Frequently Asked Questions


The current price of 600196 is 24.00 CNY — it has increased by 0.21% in the past 24 hours. Watch SHANGHAI FOSUN PHARMACEUTICAL GROUP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI FOSUN PHARMACEUTICAL GROUP stocks are traded under the ticker 600196.
600196 stock has risen by 3.49% compared to the previous week, the month change is a −2.36% fall, over the last year SHANGHAI FOSUN PHARMACEUTICAL GROUP has showed a 6.52% increase.
We've gathered analysts' opinions on SHANGHAI FOSUN PHARMACEUTICAL GROUP future price: according to them, 600196 price has a max estimate of 34.50 CNY and a min estimate of 23.00 CNY. Watch 600196 chart and read a more detailed SHANGHAI FOSUN PHARMACEUTICAL GROUP stock forecast: see what analysts think of SHANGHAI FOSUN PHARMACEUTICAL GROUP and suggest that you do with its stocks.
600196 reached its all-time high on Aug 5, 2021 with the price of 91.69 CNY, and its all-time low was 2.13 CNY and was reached on Apr 26, 2006. View more price dynamics on 600196 chart.
See other stocks reaching their highest and lowest prices.
600196 stock is 1.26% volatile and has beta coefficient of 0.98. Track SHANGHAI FOSUN PHARMACEUTICAL GROUP stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI FOSUN PHARMACEUTICAL GROUP there?
Today SHANGHAI FOSUN PHARMACEUTICAL GROUP has the market capitalization of ‪63.66 B‬, it has decreased by −10.74% over the last week.
Yes, you can track SHANGHAI FOSUN PHARMACEUTICAL GROUP financials in yearly and quarterly reports right on TradingView.
SHANGHAI FOSUN PHARMACEUTICAL GROUP is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
600196 earnings for the last quarter are 0.28 CNY per share, whereas the estimation was 0.26 CNY resulting in a 9.80% surprise. The estimated earnings for the next quarter are 0.29 CNY per share. See more details about SHANGHAI FOSUN PHARMACEUTICAL GROUP earnings.
SHANGHAI FOSUN PHARMACEUTICAL GROUP revenue for the last quarter amounts to ‪10.11 B‬ CNY, despite the estimated figure of ‪11.18 B‬ CNY. In the next quarter, revenue is expected to reach ‪10.32 B‬ CNY.
600196 net income for the last quarter is ‪759.24 M‬ CNY, while the quarter before that showed ‪785.84 M‬ CNY of net income which accounts for −3.38% change. Track more SHANGHAI FOSUN PHARMACEUTICAL GROUP financial stats to get the full picture.
Yes, 600196 dividends are paid annually. The last dividend per share was 0.27 CNY. As of today, Dividend Yield (TTM)% is 1.13%. Tracking SHANGHAI FOSUN PHARMACEUTICAL GROUP dividends might help you take more informed decisions.
SHANGHAI FOSUN PHARMACEUTICAL GROUP dividend yield was 1.19% in 2024, and payout ratio reached 28.46%. The year before the numbers were 1.08% and 30.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has ‪40.56 K‬ employees. See our rating of the largest employees — is SHANGHAI FOSUN PHARMACEUTICAL GROUP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI FOSUN PHARMACEUTICAL GROUP EBITDA is ‪5.74 B‬ CNY, and current EBITDA margin is 14.18%. See more stats in SHANGHAI FOSUN PHARMACEUTICAL GROUP financial statements.
Like other stocks, 600196 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI FOSUN PHARMACEUTICAL GROUP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI FOSUN PHARMACEUTICAL GROUP technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI FOSUN PHARMACEUTICAL GROUP stock shows the sell signal. See more of SHANGHAI FOSUN PHARMACEUTICAL GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.